You are using an older version of Internet Explorer that is not supported on this site. Please upgrade for the best experience.

Pancreatic Cancer Trials

Click on a trial to find out the eligibility requirements and who to contact if you have questions about participating.

Page 1 of 1 | Results 1 - 3 of 3

A Randomized Phase II Study of Perioperative mFOLFIRINOX (study drug) versus Gemcitabine/nab-Paclitaxel (study drug) as Therapy for Resectable Pancreatic Adenocarcinoma

The purpose of this study is to compare the effects of mFOLFIRINOX (oxaliplatin, irinotecan, and fluorouracil) and gemcitabine plus nab-paclitaxel. These chemotherapy drugs will be given before and after surgery. This study will allow the researchers to know if it is a good idea to treat pancreatic cancer with chemotherapy drugs before surgery and if so, to see which of the two drug combinations is better.
Chandravathi Loke, MD
Cancer - Pancreatic, Cancer

D'Amour Center for Cancer Care
3350 Main Street
Springfield, MA 01199

Molecular Analysis for Therapy Choice (MATCH)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA

Recruiting

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (DART)

John McCann, MD
Cancer, Cancer - Brain, Cancer - Breast, Cancer - Colon, Cancer - Esophogus, Cancer-Gynecologic, Cancer - Kidney, Cancer - Leukemia, Cancer - Lung, Cancer - Lymphoma, Cancer - Melanoma, Cancer - Multiple Myeloma, Cancer - Pancreatic, Cancer - Prostate

  • D’Amour Center for Cancer Care, 3350 Main Street, Springfield, MA
  • Baystate Franklin Medical Center, 164 High Street, Greenfield, MA   

Recruiting
Page 1 of 1 | Results 1 - 3 of 3